Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment

pharmaceutical-technologyMay 06, 2021

Tag: eFFECTOR , QBI , COVID-19 , zotatifin , DARPA

PharmaSources Customer Service